Vimarsana
Biggest News Aggregation in the World

Only Evolut News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Only Evolut. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Only Evolut Today - Breaking & Trending Today

Medtronic Evolut™ TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four years - Vimarsana News

Medtronic Evolut™ TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four years

Published: October 24, 2023

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced four-year results from the Evolut Low Risk Trial. The...

Source: prnewswire.com
Related Topics:
Prnewswire MedtronicMichael ReardonRachel MurrayMedtronic EvolutRyan WeispfenningExchange CommissionCardiovascular Research FoundationOur MissionCardiovascular ResearchJournal Of The American College CardiologyEvolut Low RiskOnly EvolutTranscatheter Cardiovascular TherapeuticsAmerican CollegeAllison Family Distinguished ChairHouston Methodist HospitalLow Risk TrialMedtronic Plc
Medtronic Evolut™ TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four years - Vimarsana News

Medtronic Evolut™ TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four years

Published: October 24, 2023

TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk TrialDUBLIN and S...

Source: businessinsider.com
Related Topics:
Michael ReardonPrnewswire MedtronicRachel MurrayRyan WeispfenningMedtronic EvolutCardiovascular Research FoundationOur MissionCardiovascular ResearchExchange CommissionJournal Of The American College CardiologyEvolut Low RiskOnly EvolutTranscatheter Cardiovascular TherapeuticsAmerican CollegeAllison Family Distinguished ChairHouston Methodist HospitalLow Risk Trial